In symptomatic isolated DVT, 12 wk vs. 6 wk of rivaroxaban reduced recurrent VTE at 24 mo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37011394.
- Also identified by DOI 10.7326/J23-0014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ageno W, Bertu L, Bucherini E, et al; RIDTS study group. <b>Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.</b> BMJ. 2022;379:e072623. 36520715.
Medical subject headings
- Venous Thrombosis
- Venous Thromboembolism
- Pulmonary Embolism